Month: November 2019

Amarin (AMRN) investors received a nice gift going into the weekend, after shares of the biopharma increased by almost 12% on Friday. The boost came on the heels of Thursday’s FDA AdCom vote in favor of extending the label on the company’s flagship drug, Vascepa, to include patients at risk of a heart attack and other major adverse cardiovascular events. The FDA is set to make a final decision on December 28, 2019.Vascepa is an FDA approved fish oil capsule used alongside a healthy diet to help lower fats (triglycerides) in the blood. The talk now turns to what level …read more […]

The Internal Revenue Service (IRS) is actively policing crypto ATMs for potential money laundering and tax issues, a top official told Bloomberg last Friday.The post IRS investigators scrutinize Bitcoin ATMs and kiosks appeared first on The Block. …read more […]

The company told Juno users on Monday its service would cease to operate that evening, directing riders instead to former competitor Lyft Inc, which it has struck a strategic partnership with. Gett and Lyft declined to provide financial details of their partnership. Gett said it would increasingly focus on the corporate transportation sector. …read more […]

Big Wall Street banks are unveiling their market outlooks for the year ahead, and Yahoo Finance’s Emily McCormick joins The Final Round to break down all the details. …read more […]

Ford’s latest foray into the electric vehicle space is with the Mustang Mach-E. The all electric SUV is available for preorder, and putting Ford in competition with Tesla. Yahoo Finance’s Rick Newman discusses Elon Musk’s influence on Ford’s newest vehicle. …read more […]

Are the prices of things you buy going up?
Sure, inflation is low at 1.8% – but how about the prices of things you actually buy?
Food prices have climbed 2.1% over the past 12 months, a little higher than the overall rate of inflation. Water bills increased an average of 3.6% this year.
By the end of 2019, electricity prices are forecast to climb 3.6%. Despite Washington’s bluster, drug prices are expected to rise 4.5% in 2020.
And if you’re going to be paying college tuition like I will be for the next seven years (two kids, not one who’s taking his time), …read more […]

The streaming wars are going to end in a two-horse race between Netflix and Disney+. …read more […]

(Bloomberg) — You’d expect most companies accused of a longstanding fraudulent scheme to be thrilled if the government dropped those claims against them. Not so for Exxon Mobil Corp. — at least not today.The energy giant unleashed a torrent of criticism against New York Attorney General Letitia James in court filings Monday, more than a week after the state sought to drop two fraud claims on the last day of a civil trial that has yet to be decided by the judge. Exxon says the government couldn’t prove the allegations and only made them “to score headlines and political points.”New …read more […]

Guru’s firm buys Brookfield, sells Ameritrade and Ubiquiti Continue reading… …read more […]

(Bloomberg) — Some of the least-loved stocks to make their debuts this year are rallying on Monday as the S&P 500 Index hovers in record territory.Fitness company Peloton Interactive Inc. gained 11% to a record high, closing above its IPO price of $29 for the first time. At its low last month, the stock was down 27% from its September IPO price, after falling amid concerns over its path to profitability. Lyft Inc. rose 4.2%, to its highest in almost two months, after picking up corporate clients in a deal with rival Juno, which is closing its New York-based operations. …read more […]